Adult iatrogenic Cushing's syndrome induced by topical skin corticosteroid misuse

Therapie. 2019 Oct;74(5):547-549. doi: 10.1016/j.therap.2019.03.005. Epub 2019 Apr 3.

Authors

Simone Negrini¹, Giuseppe Murdaca², Diego Ferone³, Matteo Borro²

Affiliations

¹ Department of Internal Medicine, Clinical Immunology Unit, University of Genoa and Policlinico San Martino, 16132 Genova, Italy. Electronic address: negrini@unige.it.
² Department of Internal Medicine, Clinical Immunology Unit, University of Genoa and Policlinico San Martino, 16132 Genova, Italy.
³ Department of Internal Medicine, Endocrinology Unit, University of Genoa and Policlinico San Martino, 16132 Genova, Italy.

PMID: 31023618
DOI: 10.1016/j.therap.2019.03.005

No abstract available

Keywords: Clobetasol propionate cream; Cushing's syndrome; Psoriasis; Topical corticosteroids.

Publication types

Case Reports
Letter

MeSH terms

Adrenocorticotropic Hormone / blood
Adult
Clobetasol / administration & dosage
Clobetasol / adverse effects*
Cushing Syndrome / chemically induced*
Cushing Syndrome / pathology
Cyclosporine / therapeutic use
Dermatologic Agents / therapeutic use
Female
Glucocorticoids / administration & dosage
Glucocorticoids / adverse effects*
Humans
Iatrogenic Disease
Prescription Drug Overuse / adverse effects*
Psoriasis / drug therapy

Substances

Dermatologic Agents
Glucocorticoids
Cyclosporine
Adrenocorticotropic Hormone
Clobetasol